| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919124 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
IC in patients with oropharyngeal carcinoma results in substantial reductions in GTVs. If post-IC GTVs are used, which is contrary to current consensus, statistically significant but relatively small OAR dose reductions are observed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Patricia Doornaert, Max Dahele, Wilko F.A.R. Verbakel, Omar Bohoudi, Ben J. Slotman, Johannes A. Langendijk,